An Assay that Predicts In Vivo Efficacy for DNA Aptamers that Stimulate Remyelination in a Mouse Model of Multiple Sclerosis

Multiple sclerosis (MS) is a debilitating disease for which regenerative therapies are sought. We have previously described human antibodies and DNA aptamer-streptavidin conjugates that promote remyelination after systemic injection into mice infected by Theiler’s murine encephalomyelitis virus. Her...

Descripción completa

Detalles Bibliográficos
Autores principales: Heider, Robin M., Smestad, John A., Lemus, Hernan Nicolas, Wilbanks, Brandon, Warrington, Arthur E., Peters, Justin P., Rodriguez, Moses, Maher, L. James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918178/
https://www.ncbi.nlm.nih.gov/pubmed/29707601
http://dx.doi.org/10.1016/j.omtm.2018.03.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918178/
https://www.ncbi.nlm.nih.gov/pubmed/29707601
http://dx.doi.org/10.1016/j.omtm.2018.03.005

Ejemplares similares